05267nam 2200625Ia 450 991014489410332120170809153834.01-280-33959-497866103395940-470-01653-10-470-01652-3(CKB)1000000000239705(EBL)244861(OCoLC)72161701(SSID)ssj0000203802(PQKBManifestationID)11181583(PQKBTitleCode)TC0000203802(PQKBWorkID)10173845(PQKB)10308624(MiAaPQ)EBC244861(EXLCZ)99100000000023970520050429d2005 uy 0engur|n|---|||||txtccrThe mobile multimedia business[electronic resource] requirements and solutions /Bernd EylertChichester ;Hoboken, NJ John Wiley & Sonsc20051 online resource (327 p.)Description based upon print version of record.0-470-01234-X Includes bibliographical references (p. [293]-295) and index.The Mobile Multimedia Business; Contents; Preface; Foreword by Jean-Pierre Bienaimé; Foreword by Tom Wheeler; Acknowledgements; 1 Introduction; 1.1 The 3G Mobile Pathfinders: Existing Wireless Communication Systems; 1.1.1 Analogue Cellular; 1.1.2 Cordless Systems; 1.1.3 Professional Mobile Radio; 1.1.4 Terrestrial Trunked Radio (TETRA); 1.1.5 Short Range Radio; 1.1.6 Mobile Satellite Systems; 1.1.7 International Maritime Satellite Organization: Inmarsat; 1.1.8 IRIDIUM and Globalstar; 1.1.9 Paging Systems; 1.1.10 In-Flight Telephone; 1.2 The History of 3G; 2 Mobile Communications Markets2.1 Market Analysis2.1.1 Market Expectations and Forecasts at the Time of Licensing the First 3G/UMTS Networks (c. 1999); 2.1.2 Customers' Expectations; 2.1.3 The Technology Background; 2.1.4 Market Dynamics; 2.1.5 General Principles for Preparing a Market Study; 2.1.6 Study Methodology; 2.2 The Market Studies of the UMTS Forum; 2.2.1 Short Summary of the Study; 2.2.2 Study Framework; 2.3 Calculations; 2.3.1 Business Models for 3G Services; 2.3.2 User Profits and Needs by Service; 2.3.3 Price Trends; 2.3.4 3G Market Demand Forecasts2.3.5 Worldwide and Regional Revenue Forecast by Service Categories2.3.6 Regional Forecasts for Selected Services: 2000-2010; 2.4 Expectations; 2.4.1 Business Implications; 2.4.2 Chances for 3G; 2.4.3 Barriers for 3G; 3 Services and Applications; 3.1 Introduction; 3.1.1 The 3G Business Chain; 3.1.2 The Move to Multi-Service Market Opportunities; 3.1.3 Quality of Service; 3.2 Description of Some Services and Applications; 3.2.1 Entertainment; 3.2.2 Mobile Shopping; 3.2.3 Experts on Call; 3.2.4 Remote Monitoring; 3.2.5 Telematics/Telemetry/Monitoring; 3.2.6 Advantages for Mobile Workers3.3 Portals and their Business Models3.3.1 Defining a Portal; 3.3.2 Key Success Factors; 3.3.3 Portal and Content; 3.3.4 The Important Role of Video in the Context of Portals; 3.3.5 Positioning of Network Operators within the Portal Industry; 3.3.6 The Role of an Internet Service Provider; 3.3.7 The Role of the Content Provider; 3.3.8 Requirements for Portal Set-Up; 3.4 Service Providers' Business Strategies; 3.4.1 The Billing Challenges and Opportunities; 3.4.2 Privacy, Data Protection and Legal Interception; 3.4.3 Harmful and Illegal Content and Protection of Minors and Public Order3.5 Mobile Internet Protocol3.6 IP Multimedia Subsystem: Service Aspects; 3.6.1 Definition; 3.6.2 The IMS Vision; 3.6.3 Internetwork Interoperability; 3.6.4 Voice Over IP; 3.6.5 IMS in Summary and Conclusion; 3.7 Naming, Addressing and Other Identifiers; 3.7.1 Naming; 3.7.2 Addressing; 3.7.3 Other Identifiers; 3.7.4 Benefits and Drawbacks of a Mobile Top-Level Domain; 4 Technology; 4.1 The ITU IMT-2000 Family Concept; 4.2 Technology Competitors; 4.3 Impact on Standardisation; 4.3.1 Mobile Multimedia Portal Platform; 4.3.2 Mobility; 4.3.3 Security; 4.3.4 Further Aspects4.4 Terminals and DevicesAs the wireless world opens up, this book explores the evolving role of multimedia and UMTS technology in the mobile communications sector. The author draws on his extensive experience in the field to provide an approach that will appeal to academia and industry alike, covering hot topics such as regulation and licensing, services and applications, markets, security, devices and terminals and charging schemes. Numerous examples from international sources are used to illustrate the current status of the technology around the globe, examining the implications of its evolution to 4G. <ul type=""dMobile communication systemsMultimedia communicationsElectronic books.Mobile communication systems.Multimedia communications.384.533384/.09/051Eylert Bernd896380MiAaPQMiAaPQMiAaPQBOOK9910144894103321The mobile multimedia business2002571UNINA03636nam 2201093z- 450 991036774630332120231214132925.03-03921-807-7(CKB)4100000010106254(oapen)https://directory.doabooks.org/handle/20.500.12854/57236(EXLCZ)99410000001010625420202102d2019 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierProtective and Detrimental Role of Heme Oxygenase-1MDPI - Multidisciplinary Digital Publishing Institute20191 electronic resource (220 p.)3-03921-806-9 The book “Protective and Detrimental Role of Heme Oxygenase-1”, includes a selection of original research papers and reviews aimed at understanding the dual role (protective and detrimental) of HO-1 and the involved signaling pathways. Original research papers and reviews aimed at the identification of natural molecules or new synthetic compounds able to modulate HO-1 activity/expression help make HO-1 a potential therapeutic target for the amelioration of various diseases.coronary artery diseaseglucocorticoid receptorantigen presentationanalgesiachemotherapylocus coeruleusSirtuin 1thiol groupsHeme Oxygenase-1Betula etnensis Raf.heme oxygenase 1toleranceheme oxygenaseatherosclerosisnitric oxidecaloric restrictionlivercarbon monoxideER stressheme oxygenase-1mineralocorticoid receptorType 1 diabetes mellitus (T1D)Gamma-Glutamyl-Cysteine Ligase (GGCL)angiotensin IIbilirubinHeme oxygenase-1 (HO-1) inducersInducible nitric oxide synthase (iNOS)HO-1 activity inhibitorferroptosisMyristica fragrans kernelsglutathionehigh-pressure gasapoptosisHO-1diabetes mellitusCaffeic acid phenethyl ester (CAPE)carotid plaqueischemia-reperfusion injuryANTIGEN presenting cellLPSendoplasmic reticulum stresshemoglobinPancreatic oxidative damageColon cancerinflammationreactive oxygen speciesinflammatory painparacetamolcardiomyopathyheme oxigenase-1adipocytessirtuin 1peripheral artery diseasePGC-1?hemeReactive oxygen species (ROS)metforminGRprostate cancerNF-?BhyperbilirubinemiaironTet-ON systemlung preservationoxidative stressGunn ratsDimethylarginine dimethylaminohydrolase-1 (DDAH-1)Sorrenti Valeriaauth1314801BOOK9910367746303321Protective and Detrimental Role of Heme Oxygenase-13031983UNINA04748nam 2201153z- 450 991055729510332120231214133416.0(CKB)5400000000041088(oapen)https://directory.doabooks.org/handle/20.500.12854/69348(EXLCZ)99540000000004108820202105d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierRadiolabelled Molecules for Brain Imaging with PET and SPECTBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20201 electronic resource (244 p.)3-03936-720-X 3-03936-721-8 Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are in vivo molecular imaging methods which are widely used in nuclear medicine for diagnosis and treatment follow-up of many major diseases. These methods use target-specific molecules as probes, which are labeled with radionuclides of short half-lives that are synthesized prior to the imaging studies. These probes are called radiopharmaceuticals. The use of PET and SPECT for brain imaging is of special significance since the brain controls all the body’s functions by processing information from the whole body and the outside world. It is the source of thoughts, intelligence, memory, speech, creativity, emotion, sensory functions, motion control, and other important body functions. Protected by the skull and the blood–brain barrier, the brain is somehow a privileged organ with regard to nutrient supply, immune response, and accessibility for diagnostic and therapeutic measures. Invasive procedures are rather limited for the latter purposes. Therefore, noninvasive imaging with PET and SPECT has gained high importance for a great variety of brain diseases, including neurodegenerative diseases, motor dysfunctions, stroke, epilepsy, psychiatric diseases, and brain tumors. This Special Issue focuses on radiolabeled molecules that are used for these purposes, with special emphasis on neurodegenerative diseases and brain tumors.Research & information: generalbicsscBiology, life sciencesbicsscSV2ASV2BSV2CmicroPET[18F]UCB-HepilepsyPBIFdistribution volumeblocking assaypreclinical imagingAlzheimer’s disease (AD)network measuregraph theorybrain networkpositron emission tomography (PET)persistent homologyPhosphodiesterase 2A (PDE2A)Positron Emission Tomography (PET)Benzoimidazotriazine (BIT)fluorinatedMouse Liver Microsomes (MLM)cyclic nucleotide phosphodiesterasePDE2A radioligandnitro-precursorfluorine-18in vitro autoradiographyPET imagingopioid receptorspositron emission tomographyradiotracersμOR-, δOR-, κOR- and ORL1-ligandsmovement disorderspaindrug dependenceGBMbiomarkersSigma 1Sigma 2PD-L1PARPIDHAlzheimer’s diseaseParkinson’s diseaseβ-amyloid plaquesneurofibrillary tanglesα-synucleinopathydiagnostic imaging probesorexin receptorsPETradiotracerimagingalpha 7nicotinic acetylcholine receptorsnAChRautoradiographyamino acidFETFACBCFDOPAimmunoPETmolecular imaginggliomabrain metastasesadenosine A2A receptorrotenone-based mouse model[18F]FESCHtwo-step one-pot radiosynthesisResearch & information: generalBiology, life sciencesBrust Peteredt1291783Brust PeterothBOOK9910557295103321Radiolabelled Molecules for Brain Imaging with PET and SPECT3021916UNINA